VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) is scheduled to present at the 16th Annual World Vaccine Congress Europe on Tuesday, November 10th, 2015 at 6:30 AM ET (12:30 PM CET)….

Respiratory syncytial virus (“RSV”) is a significant cause of disease in infants and young children, but is also an important cause of respiratory infection in the elderly, the immunocompromised, and…

Respiratory syncytial virus (“RSV”) is a respiratory virus that infects the lungs and airways. While healthy people typically experience only mild, cold-like symptoms, and quickly recover, RSV can cause serious…
VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) has been awarded up to $350,000 CAD in grant funding by the National Research Council-Industrial Research Assistance Program (“NRC-IRAP”) to apply VBI’s eVLP Platform…